Non-invasive Remote Ischemic PreConditioning (RIPC) in Free Flaps for Breast Reconstruction
NCT: NCT07487220 · COMPLETED
Brief Summary
This prospective randomized clinical study investigates the effects of Remote Ischemic Conditioning (RIC) on tissue perfusion and ischemia-reperfusion injury in patients undergoing free flap reconstruction in reconstructive microsurgery. RIC is a non-invasive conditioning technique using cyclic ischemia and reperfusion applied to an extremity, which may enhance microcirculation and induce tissue protection. The study aims to evaluate whether preoperative RIC improves postoperative flap perfusion, reduces ischemia-reperfusion- related tissue damage, and enhances clinical outcomes such as flap survival, wound healing, and need for revision surgery. Patients undergoing free flap procedures will be randomized to receive either preoperative RIC (immediate or delayed) or no conditioning. Additional analyses include continuous postoperative monitoring of microcirculation, histological and molecular assessment of tissue samples, and evaluation of circulating biomarkers associated with tissue protection.
Frequently Asked Questions
What is Non-invasive Remote Ischemic PreConditioning (RIPC) in Free Flaps for Breast Reconstruction?
Non-invasive Remote Ischemic PreConditioning (RIPC) in Free Flaps for Breast Reconstruction is a clinical trial registered under NCT07487220. Current status: COMPLETED.
What is the status of NCT07487220?
The current status of NCT07487220 (Non-invasive Remote Ischemic PreConditioning (RIPC) in Free Flaps for Breast Reconstruction) is: COMPLETED.
When did Non-invasive Remote Ischemic PreConditioning (RIPC) in Free Flaps for Breast Reconstruction start?
Non-invasive Remote Ischemic PreConditioning (RIPC) in Free Flaps for Breast Reconstruction started on 2021-04-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.